Research Article
Bioaccessibility and Pharmacokinetics of a Commercial Saffron (Crocus sativus L.) Extract
Table 3
Baseline demographic details of participants.
| Demographics | Total (N = 13) | Treatment groups | affron® 56 mg (n = 7) | affron® 84 mg (n = 6) |
| Mean age (SD) | 23.6 (2.9) | 23.0 (2.0) | 24.6 (3.9) | Age range (years) | 19–30 | 20–26 | 19–30 | Gender (number, %) | | | | Female | 8 (61.5%) | 4 (57.1%) | 4 (66.6%) | Male | 5 (38.5%) | 3 (42.9%) | 2 (33.4%) | Weight (SD) | | | | Female | 59.0 (4.2) | 58.9 (3.7) | 59.1 (4.8) | Male | 83.2 (5.7) | 82.9 (5.3) | 83.6 (6.1) |
|
|